NR3C1 and ACTH-producing pituitary gland adenoma: Silibinin, a C-terminal HSP90 inhibitor, increased the transcriptional activity of NR3C1 in murine corticotroph cells and enhanced the suppression of ACTH secretion in primary corticotroph adenoma cell cultures, restoring glucocorticoid sensitivityin vitro.